Cardinal Health (NYSE:CAH) is expanding production capacity for the medical radioisotope Actinium-225 to support targeted alpha therapies for cancer treatment worldwide. The company is positioning ...

Cardinal Health stock is being upgraded to a buy rating, from my prior hold rating last year, agreeing with the SA analyst consensus today. Bullish drivers include recent revenue/earnings growth, ...

Brown Advisory, an investment management company, released its “Brown Advisory Mid-Cap Growth Strategy” fourth-quarter 2025 ...

In the latest close session, Cardinal Health (CAH) was up +2.42% at $211.31. The stock fell short of the S&P 500, which registered a gain of 2.91% for the day. Meanwhile, the Dow gained 2.49%, and the ...

Cardinal Health recalled some of its Webcol Large Alcohol Prep Pads as they may contain the bacteria Paenibacillus phoenicis.

Feb 1 (Reuters) - Cardinal Health (CAH.N), opens new tab lowered the full-year profit forecast for its medical segment on Thursday, taking the shine off the company's upbeat second-quarter results and ...

Cardinal Health, which manufactures and distributes medical and laboratory products, has entered into a definitive agreement to acquire Integrated Oncology Network, a physician-led independent ...

Cardinal Health is building another warehouse in central Ohio as the wholesale drug distribution and medical supply company builds out capacity for the distribution for over-the-counter consumer ...

In the most recent trading session, Cardinal Health (CAH) closed at $211.87, indicating a -2.08% shift from the previous ...

Cardinal Health Inc. announced Wednesday an agreement to buy Specialty Networks for $1.2 billion in cash, as the drug distributor and medical products maker looks to enhance its data analytics ...